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NEW FINDINGS: 22	
What is the central question of this study? 23	
Critical power (CP) is a fundamental parameter defining high-intensity exercise tolerance, 24	
and is related to the phase II time constant of pulmonary oxygen uptake kinetics (𝜏!O2). To 25	
test whether this relationship is causal, we assessed the impact of hyperoxia on 𝜏!O2 and CP 26	
during supine cycle exercise. 27	
What is the main finding and its importance? 28	
The results demonstrate that hyperoxia increased muscle oxygenation, reduced 𝜏!O2 (i.e. sped 29	
the 𝑉O2 kinetics), and subsequently, increased critical power when compared to normoxia. 30	
These results therefore suggest that 𝜏!O2 is a determinant of the upper limit for steady-state 31	
exercise, i.e. critical power. 32	
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ABSTRACT 42	
The present study determined the impact of hyperoxia on the phase II time constant of 43	
pulmonary oxygen uptake kinetics (𝜏!O2) and critical power (CP) during supine cycle 44	
exercise. 8 healthy males completed an incremental test to determine maximal oxygen uptake 45	
and the gas exchange threshold (GET). Eight separate visits followed, whereby CP, 𝜏!O2 and 46	
absolute concentrations of oxyhaemoglobin ([HbO2]; via near-infrared spectroscopy) were 47	
determined via four constant-power tests to exhaustion, each repeated once in normoxia and 48	
once in hyperoxia (FiO2 = 0.5). A 6-minute bout of moderate intensity exercise (70% GET) 49	
was also undertaken prior to each severe intensity bout, in both conditions. CP was greater 50	
(hyperoxia = 148 ± 29 W vs. normoxia = 134 ± 27 W, P = 0.006) and the 𝜏!O2 was reduced 51	
(hyperoxia = 33 ± 12 s vs. normoxia = 52 ± 22 s, P = 0.007) during severe exercise in 52	
hyperoxia when compared to normoxia. Furthermore, [HbO2] was enhanced in hyperoxia 53	
compared to normoxia (hyperoxia: 67 ± 10 versus normoxia: 63 ± 11 µM; P = 0.020).  𝜏!O2 54	
was significantly related to CP in hyperoxia (R2 = 0.89, P < 0.001), however no relationship 55	
was observed in normoxia (R2 = 0.03, P = 0.68). Muscle oxygenation was increased, 𝜏!O2 56	
was reduced and CP was increased in hyperoxia compared to normoxia, suggesting that 𝜏!O2 57	
is an independent determinant of CP. That 𝜏!O2 was related to CP in hyperoxia but not 58	
normoxia further supports this notion.  59	
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INTRODUCTION 66	
The tolerable duration of high-intensity exercise is well described by a two-parameter  67	
hyperbolic relationship between power and duration (Moritani et al., 1981; Poole et al., 68	
1988). The asymptote of this relationship is termed “critical power”, with W’ representing the 69	
rectangular constant of the hyperbola, equivalent to a fixed quantity of work performable 70	
above critical power.  The functional significance of critical power is demonstrated by the 71	
observation that pulmonary oxygen uptake (𝑉O2) and muscle metabolic variables (e.g. 72	
muscle lactate concentration, [L-]; [H+]; phosphocreatine concentration, [PCr]; [Pi]) do not 73	
reach a steady-state during exercise above critical power. Instead these parameters achieve 74	
consistently high (e.g. 𝑉O2, [L-], [H+], [Pi]) or low ([PCr]) values at the limit of tolerance 75	
(Black et al., 2017; Jones et al., 2008; Vanhatalo et al., 2016). Critical power therefore 76	
represents a metabolic rate (i.e. a “critical 𝑉O2”) that demarcates the boundary between 77	
steady-state (heavy-intensity) and non-steady-state (severe-intensity) exercise (Poole et al., 78	
2016). Exercise performed at a metabolic rate exceeding critical power will therefore become 79	
predictably limited in accordance with the parameters of the power-duration relationship and 80	
their physiological corollaries. These physiological corollaries therefore define the tolerable 81	
duration of severe-intensity exercise, yet remain incompletely understood. 82	
At the onset of muscular work, pulmonary 𝑉O2 kinetics increase in a near-exponential 83	
fashion with a time constant (𝜏!O2) that closely approximates that of muscle 𝑉O2 (Grassi et 84	
al., 1996). A strong inverse relationship has been observed between 𝜏!O2 and critical power 85	
during upright cycle exercise (Murgatroyd et al., 2011; Goulding et al., 2017, 2018a), 86	
suggesting that these parameters may be causally related. In support of this we recently 87	
showed that a prior bout of heavy-intensity “priming” exercise reduced 𝜏!O2 and increased 88	
critical power (Goulding et al., 2017). However the concomitant improvements in critical 89	
power and 𝜏!O2 may have been due to the enhanced O2 availability that attended priming 90	
exercise, rather than a dependence of critical power on 𝜏!O2 per se.  Subsequent to this study, 91	
we demonstrated a concomitant increase in 𝜏!O2 and reduction in critical power, independent 92	
of O2 availability, when exercise was initiated from an elevated moderate-intensity baseline 93	
work rate compared to a baseline of unloaded cycling  (i.e. “work-to-work” cycle exercise) in 94	
both the upright and supine position (Goulding et al., 2018a, 2018b). Taken together, these 95	
findings strongly suggest a prevailing dependence of critical power on 𝜏!O2.  96	
Despite our recent data (Goulding et al., 2017, 2018a, 2018b), stronger evidence for a 97	
determining effect of 𝜏!O2 on critical power would arguably come from the establishment of 98	
a relationship between the changes in critical power (ΔCP) and 𝜏!O2 (Δ𝜏!O2) between two 99	
conditions where 𝜏!O2 would be expected to differ. However, a valid assessment of this 100	
relationship requires the precise characterisation of the value of 𝜏!O2 via repeated, identical 101	
exercise transitions in each condition (Lamarra et al., 1987; Whipp et al., 1982). In contrast, 102	
our previously employed interventions (i.e. priming exercise and work-to-work exercise; 103	
Goulding et al., 2017, 2018a, 2018b) precluded the precise characterisation of the value of 104	
𝜏!O2 in each condition since this would have placed undue time commitments on the 105	
participants. Conversely, inspired hyperoxic air has the potential to reduce 𝜏!O2, at least 106	
during supine exercise where O2 delivery is rate-limiting (Macdonald et al., 1997). However, 107	
unlike our previously imposed interventions (Goulding et al., 2017, 2018a, 2018b), hyperoxia 108	
does not require a prolonged wash-out period before the physiological responses to further 109	
exercise can be considered as being normal. Hence during supine exercise, hyperoxia 110	
represents a convenient means by which to manipulate 𝜏!O2, observe any effect on critical 111	
power, and precisely characterise 𝜏!O2 via bouts of moderate intensity exercise undertaken 112	
shortly prior to the criterion bouts that determine critical power. This enables a valid 113	
assessment of Δ𝜏!O2 versus ΔCP to be undertaken, with the establishment of a Δ𝜏!O2 – ΔCP 114	
relationship providing definitive support for a mechanistic role of 𝜏!O2 in determining critical 115	
power.   116	
The aim of the present study was therefore to determine the impact of hyperoxia on 𝜏!O2 and 117	
critical power during supine exercise, with 𝜏!O2 precisely characterised via multiple bouts of 118	
identical exercise in each condition. We hypothesised that (1) hyperoxia would reduce 𝜏!O2 119	
compared to normoxia, (2) hyperoxia would increase critical power compared to normoxia, 120	
(3) ΔCP would correlate with Δ𝜏!O2.  121	
METHODS 122	
Ethical approval. The experiment was approved by Liverpool Hope University Research 123	
Ethics Committee (approval reference number: S-15-06-2017 PA 015). The experiment 124	
conformed to the standards set by the Declaration of Helsinki, except for registration in a 125	
database. All participants provided written informed consent. 126	
Participants. Eight healthy male subjects (mean ± SD, age = 22 ± 3 years; height = 180 ± 9 127	
cm; mass = 80 ± 9 kg) participated. Participants were instructed to avoid alcohol and 128	
strenuous exercise 24 h prior to each visit, not to consume caffeine 3 h prior to each visit, and 129	
to arrive 3 h postprandial. Tests were separated by at least 24 h, with each test performed at 130	
the same time of day (± 2 h). 131	
Procedures. All tests took place in a temperature-controlled laboratory (maintained between 132	
18-21 oC). The experiment involved nine visits over a 3-5 week period, including one 133	
preliminary trial and eight experimental trials. All tests were performed on a supine cycle 134	
ergometer, which consisted of an electronically-braked ergometric unit (Lode Angio, 135	
Groningen, The Netherlands) positioned on an Echo Cardiac Stress Table (Lode, Groningen, 136	
The Netherlands). The ergometric unit was positioned such that the quadriceps were above 137	
the level of the heart during exercise. Participants lay supine on the table whilst exercising, 138	
and hand rails were available for participants to grip throughout the tests to prevent 139	
backwards movements from occurring when forces were applied to the pedals. An adjustable 140	
shoulder pad was positioned above the participant’s shoulder to further impede any rear 141	
movements. Participant’s feet were securely strapped to the pedals throughout all tests. The 142	
position of the shoulder pad and the distance between the hip and the crank, as well as each 143	
participant’s chosen hand grip position, was recorded at the first visit and replicated during 144	
each subsequent visit. Throughout all exercise tests, participants were instructed to cycle at a 145	
self-selected cadence between 70-90 rev/min (which was recorded and replicated in 146	
subsequent visits), with task failure being defined as the point at which the cadence dropped 147	
below 50 rev/min. The limit of tolerance was recorded to the nearest second in all tests.  148	
Preliminary trial. Following measurement of height and weight, participants performed an 149	
incremental ramp test to the limit of tolerance to determine 𝑉O2 max and the gas exchange 150	
threshold (GET), such that the power outputs for subsequent visits could be calculated. The 151	
ramp test consisted of 3 min baseline pedalling at 30 W, followed by a ramped increase in 152	
power of 25 W.min-1 until task failure occurred. Ventilatory and gas exchange variables were 153	
measured continuously breath-by-breath throughout each test. 𝑉O2 max was defined as the 154	
highest 30 s value recorded throughout the test. The GET was estimated via visual 155	
determination of the time point at which the following occurred: 1) increased CO2 production 156	
(𝑉CO2) compared to 𝑉O2, 2) increased minute ventilation (𝑉E) relative to 𝑉O2 (𝑉E/𝑉O2) 157	
without an increase in 𝑉E/𝑉CO2, and 3) an increase in end tidal O2 tension without 158	
decreasing end tidal CO2 tension. The mean response time (MRT) was defined as the time 159	
between the beginning of the ramp test and intersection between baseline 𝑉O2 (average 𝑉O2 160	
measured during last 30 s of baseline; 𝑉O2b) and backwards extrapolation of the 𝑉O2-time 161	
relationship (Boone et al., 2008). This technique was also used to calculate power outputs for 162	
subsequent visits.  163	
Experimental trials. The eight experimental trials that followed required exercise at four 164	
fixed severe-intensity power outputs performed until the limit of tolerance. Each power 165	
output was repeated twice, i.e. once in normoxia (breathing room air) and once in hyperoxia 166	
(fraction of inspired O2 0.5; British Oxygen Company). The power outputs were estimated to 167	
be in the range of 50%Δ (i.e. 50% of the difference between the GET and 𝑉O2 max) – 110% 168	
𝑉O2 max, such that the range of exercise tolerance times was 2-15 minutes for each subject 169	
(Hill, 1993). If tolerance time for a particular test fell outside of this range, the power output 170	
was modified and the test repeated on a subsequent day. The four power outputs utilised for 171	
each participant will hereafter be referred to as WR1, WR 2, WR 3, and WR 4, with WR 1 172	
being the lowest and WR 4 being the highest power outputs, respectively. Power outputs 173	
were presented in random order, with participants alternating between normoxic and 174	
hyperoxic conditions. In both normoxia and hyperoxia, tests began with 3 minutes of 20 W 175	
baseline cycling, before a step change in power output to 70% GET for 6 minutes. The 176	
purpose of the 6 minute bout of moderate exercise was to precisely characterise 𝑉O2 kinetics 177	
in each condition via averaging of multiple identical trials (see data analysis) to facilitate 178	
comparisons of the magnitude of change of related parameters between conditions. After 179	
these 6 minutes of moderate cycling, the power output was reduced to 20 W for a further 10 180	
minutes. Subsequent to these 10 minutes of 20 W cycling, a step increase in power output 181	
was abruptly applied to the desired severe-intensity (i.e. WR’s 1-4), and participants 182	
exercised until the limit of tolerance was reached.  183	
Participants wore a silicone face mask (Hans Rudolph, Kansas, United States) with a flow 184	
sensor (Geratherm Respiratory, GmbH, Germany) attached, which was attached in turn via a 185	
capillary line to a metabolic cart (Blue Cherry, Geratherm Respiratory, GmbH, Germany) 186	
that was used to measure pulmonary gas exchange and ventilation breath-by-breath 187	
throughout all tests. Gases of known concentration were used to calibrate gas analysers, and a 188	
3-liter syringe (Hans Rudolph, Kansas City, MO) was used to calibrate flow sensors. A two-189	
way non-rebreathing valve (Hans Rudolph T-Shape Two-Way Non-Rebreathing Valve Series 190	
2600; Hans Rudolph, Kansas, United States) was attached to the flow sensor via a piece of 191	
rubber tubing. A 200 L Douglas bag was connected to the inlet port of this valve. In the 192	
hyperoxic condition, Douglas bags were continuously filled with the 50% O2 gas mixture via 193	
a pressurised cylinder, and in the normoxic condition the Douglas bag was bypassed so that 194	
participants breathed room air. In the hyperoxic condition, participants rested quietly on the 195	
ergometer for 10 minutes before exercise to allow body O2 stores to become equilibrated, a 196	
procedure that was also replicated in the normoxic condition with participants inhaling room 197	
air. Heart rate was determined every 1 s throughout all tests using short-range radiotelemetry 198	
(Garmin FR70, Garmin Ltd., Switzerland). In both conditions, blood was drawn from the 199	
thumb of the right hand at rest, during the final minute of baseline pedalling prior to the onset 200	
of severe exercise, and immediately upon reaching the limit of tolerance. Whole blood [L-] 201	
was determined using a Biosen C-Line lactate analyser (EKF, Germany). 202	
Absolute concentrations of muscle and microvascular deoxyhaemoglobin + deoxymyoglobin 203	
([HHb + Mb]), oxyhaemoglobin + oxymyoglobin ([HbO2 + MbO2]), and total haemoglobin + 204	
total myoglobin ([THb + Mb]) were determined using a frequency-domain multidistance 205	
NIRS system (OxiplexTS, ISS, Chapaign, IL, USA). This technique has been described in 206	
detail previously (Broxterman et al., 2014; Goulding et al., 2017). Briefly, this device 207	
consists of one detector fibre bundle and eight light-emitting diodes (LED) operating at 208	
wavelengths of 690 and 830 nm (four LEDs per wavelength), with LED-detector fibre bundle 209	
separation distances of 2.25, 2.75, 3.25 and 3.75. The device measures and incorporates 210	
dynamic reduced scattering coefficients to provide absolute concentrations of [HHb + Mb] 211	
and [HbO2 + MbO2]. The NIRS probe was calibrated prior to each test according to the 212	
manufacturer’s instructions. Two flexible NIRS probes were placed on the participant; one 213	
longitudinally along the belly of the right vastus lateralis (VL), the other longitudinally along 214	
the belly of the rectus femoris (RF) muscle. The probes were held firmly in place via Velcro 215	
strapping, and the area underneath the probe was cleaned, shaved and marked with pen such 216	
that probe position could be accurately replicated for each trial. Measurements began with 217	
participants in a resting position on the ergometer, with feet strapped into the pedals and the 218	
right leg extended. To account for the influence of adipose tissue thickness (ATT) on the 219	
NIRS signal, we employed the correction factor employed by Craig et al. (2017), i.e. with 220	
separate correction factors for the RF and VL (Figure 1). 221	
Data analysis. Breath-by-breath 𝑉O2 data were edited to remove data points lying more than 222	
4 standard deviations (SD) outside the local 5-breath mean (Lamarra et al., 1987). These data 223	
were then linearly interpolated to provide second-by-second values. For 𝑉O2, [HHb + Mb], 224	
[HbO2 + MbO2] and heart rate data in response to moderate exercise transitions, second-by-225	
second data for the four identical transitions were averaged together to produce a single 226	
dataset. The severe-intensity exercise bouts for each condition were not repeated and were 227	
therefore modelled separately. The following mono-exponential function was then used to fit 228	
the 𝑉O2, [HHb + Mb] and heart rate responses to exercise: 229	
(1) Y(t) = Y(b) + AY * (1 – e – (t – TD/ τ)) 230	
 231	
Where Y(t) is the value of the independent variable at time t, Y(b) is the baseline value 232	
measured over the final 30 seconds of baseline pedalling, AY is the amplitude of increase in Y 233	
above baseline, TD is the time delay and τ is the time constant of the response. For 𝑉O2, the 234	
end of the “cardiodynamic” phase was determined to be the time at which a drop in 235	
respiratory exchange ratio and end-tidal O2 pressure was observed, and data preceding this 236	
point were excluded from the modelling process. For moderate exercise, 𝑉O2 responses were 237	
fit to 360 s. During severe transitions, the onset of the 𝑉O2 slow component was determined 238	
by progressively increasing the fitting window, beginning from the end of phase I to 60 239	
seconds and then successively extending the window to the limit of tolerance. The onset of 240	
the slow component was taken as the time point at which a departure from “flatness” in the 241	
plot of 𝜏!O2 and/or χ
2 versus time was observed, as described previously (Rossiter et al., 242	
2001; Goulding et al., 2017). This method allows fitting of the isolated fundamental 243	
component without arbitrary parameterization of the slow component. The magnitude of the 244	
𝑉O2 slow component was calculated as the difference between end exercise 𝑉O2 (i.e. mean 245	
𝑉O2 over final 30 s of exercise) and AY + Y(b). For [HHb + Mb], data preceding the time point 246	
at which the [HHb + Mb] signal increased above 1 SD of the pretransition baseline value 247	
were removed. On occasions where [HHb + Mb] decreased after the exercise onset, data 248	
preceding the first point showing a sustained increase in [HHb + Mb] were removed from the 249	
modelling process. Although [HHb + Mb] data were modelled with the TD allowed to vary 250	
freely such that the fit could be optimised, the time point at which [HHb +Mb] began to 251	
increase is presented in the results (see Table 3) as this is the more physiologically relevant 252	
parameter (Spencer et al., 2011). Heart rate increased with no TD, therefore the response was 253	
constrained to the start of exercise. For moderate exercise, [HHb + Mb] data were fit to Eq. 1 254	
using the iterative procedures described for the determination of the 𝑉O2 kinetics but with the 255	
fitting window commencing at 20 s. This modelling strategy thus allows for the 256	
determination of the optimum “phase II” fitting window even in the presence of a [HHb + 257	
Mb] overshoot. By plotting the resultant τ[HHb+Mb] values against time, and identifying the 258	
point at which a sustained decrease (overshoot) or increase in τ[HHb+Mb] was observed 259	
alongside a sharp increase in the χ2 value. For severe-intensity exercise for both [HHb + Mb] 260	
and heart rate, the model window was constrained to the time of onset of the 𝑉O2 slow 261	
component. The amplitude of the [HHb + Mb] and heart rate “slow component” during 262	
severe exercise was calculated by subtracting Y(b) + AY from the mean value of Y during the 263	
final 30 s of exercise. Intersite coefficient of variation (CV% = 100 * SD/ mean of the two 264	
sites) was calculated to quantify the spatial heterogeneity for TD[HHb+Mb] and τ[HHb+Mb]. 265	
Confidence intervals for all τ parameters were obtained in Origin 6.0 (OriginLab 266	
Corporation, MA, USA). For [HbO2 + MbO2] and [THb + Mb] during moderate exercise, 30 267	
second averages were determined at baseline, and every 30 seconds thereafter until the end of 268	
the transition. For severe exercise, mean [HbO2 + MbO2] and [THb + Mb] was determined at 269	
baseline, at 30 and 120 seconds into the transition (15 second bins centred on each time 270	
point), and at end-exercise (final 30 seconds) to allow comparisons between conditions.  271	
Critical power and W’ were determined by inputting power output (P), time to task failure (T) 272	
and work done (W) into three models: the hyperbolic power-time model (Eq. 2), the linear 273	
work-time model (Eq. 3), and the linear power versus the inverse-of-time models (4): 274	
(2)     P = W’ / T + CP         275	
(3)     W = CP * T + W’       276	
(4)     P = W’ * (1/T) + CP     277	
The standard errors of the estimates (SEE) associated with critical power and W’ were 278	
expressed as a coefficient of variation (CV) relative to the parameter estimate. Best individual 279	
fit parameter estimates were obtained for each participant by selecting the model producing 280	
the lowest summed CV for both parameters across conditions. The same model was used in 281	
both conditions for each individual participant. 282	
Statistical analyses. All kinetic parameters (i.e. 𝑉O2, [HHb + Mb], and heart rate), blood [L-], 283	
[HbO2 + MbO2], [THb + Mb] and spatial heterogeneity of [HHb + Mb] during severe 284	
exercise were analysed using two- (condition * work rate or condition * muscle), three- 285	
(condition * work rate * time or condition * muscle * time), or four-way (condition * muscle 286	
* work rate * time) repeated measures ANOVAs, as appropriate. Where significant 287	
differences were found, planned repeated and simple contrasts were used to identify the 288	
location of these differences. 𝑉O2, heart rate and spatial heterogeneity of [HHb + Mb] for 289	
moderate exercise as well as differences in critical power and W’ between conditions were 290	
compared using student’s paired t-tests. Pearson’s correlation coefficient was used to 291	
determine relationships between variables of interest. All data are presented as mean ± SD 292	
unless otherwise stated. For clarity, and to highlight values for parameters measured across 293	
all four severe-intensity work rates, the overall mean across work rates ± SD are presented in 294	
text, with work rate-specific mean ± SD presented in tables. Statistical significance was 295	
accepted at P < 0.05. 296	
RESULTS 297	
Mode-specific 𝑉O2 max determined from the ramp test was 3.26 ± 0.75 L.min-1 (40.8 ± 9.0 298	
mL.kg.min-1), and this was associated with a peak work-rate of 238 ± 39 W. The GET was 299	
1.61 ± 0.21 L.min-1 (87 ± 12 W), and as such the exercise bouts at 70% GET were conducted 300	
at 61 ± 8 W. There was no main effect of condition [hyperoxia vs. normoxia] (P = 0.51) or 301	
condition * time interaction effect (P = 0.79) on blood [L-], indicating that blood [L-] 302	
accumulation did not differ between conditions. Blood [L-] did not differ between rest and 303	
baseline (rest: 1.63 ± 0.29 mmol.L-1 versus baseline: 1.63 ± 0.37 mmol.L-1), however it rose 304	
significantly at end-exercise (8.83 ± 1.90 mmol.L-1, main effect of time, P < 0.001). 305	
There was a main effect of condition on time to task failure (P < 0.001), with time to task 306	
failure being greater at WR 1 (hyperoxia: 655 ± 158, normoxia: 482 ± 176 s) and WR 2 307	
(hyperoxia: 403 ± 95, normoxia: 278 ± 60 s) in hyperoxia compared to normoxia. Individual 308	
fit optimisation resulted in the W-T model being used for 3 participants and the hyperbolic P-309	
T model for 5 participants. CP was greater in hyperoxia than in normoxia (hyperoxia: 148 ± 310	
29, normoxia: 134 ± 27 W; P = 0.006; Table 1), whereas W’ was not different between 311	
conditions (hyperoxia: 12.8 ± 4.7 kJ, normoxia: 13.9 ± 4.7 kJ; P = 0.50; Table 1). Figure 2 312	
illustrates the effect of hyperoxia on the power-duration relationship in a representative 313	
participant.  314	
Group mean 𝑉O2 responses to moderate exercise in each condition are displayed in Figure 3, 315	
whereas 𝑉O2 responses to severe exercise at a representative work rate from a representative 316	
participant are displayed in Figure 4. 𝑉O2 peak did not differ between the constant work rate 317	
prediction trials in normoxia and the ramp incremental test (P = 0.94), nor between any of the 318	
constant work rate trials in hyperoxia (P = 0.73). 𝜏!O2 was reduced in hyperoxia compared to 319	
normoxia during both moderate exercise (hyperoxia: 33 ± 14 versus normoxia: 49 ± 14 s, P = 320	
0.019) and severe exercise (hyperoxia: 33 ± 12 versus normoxia: 52 ± 22 s, P = 0.007). There 321	
were no other differences in any of the 𝑉O2 kinetics parameters for moderate exercise (Figure 322	
3). During severe exercise, there was an increased 𝑉O2 peak (P = 0.007) in hyperoxia, with a 323	
concomitant increase in the 𝑉O2 slow component amplitude (P = 0.004) (Table 2). There 324	
were no other differences in any of the 𝑉O2 kinetics parameters for severe exercise (Table 2). 325	
 𝜏!O2 during moderate exercise in hyperoxia was inversely correlated to critical power in 326	
hyperoxia (r = -0.89, P < 0.001, Figure 5B), however no relationship was observed between 327	
𝜏!O2 during moderate exercise in normoxia and normoxic critical power (r = -0.07, P = 0.68, 328	
Figure 5A). There was no significant linear relationship between ΔCP and Δ𝜏!O2 derived from 329	
the moderate intensity bouts (r = -0.45, P = 0.27, Figure 5C). 330	
 [HbO2 + MbO2] was increased in hyperoxia during both moderate (hyperoxia: 67 ± 17 331	
versus normoxia: 63 ± 14 µM; P = 0.004, Figure 6A, 6B) and severe (hyperoxia: 67 ± 10 332	
versus normoxia: 63 ± 11 µM; P = 0.020) exercise. [THb + Mb] was unchanged between 333	
conditions during both moderate (hyperoxia: 92 ± 19 versus normoxia: 90 ± 19 µM, P = 0.23; 334	
Figure 6C, D) and severe exercise (hyperoxia: 153 ± 82 versus normoxia: 152 ± 82 µM, P = 335	
0.78).	 Baseline [HHb + Mb] was lower in hyperoxia compared to normoxia during moderate 336	
exercise (hyperoxia: 19 ± 7 versus normoxia: 22 ± 8 µM, P = 0.049; Figure 7), however there 337	
were no other differences in [HHb + Mb] kinetic parameters for either moderate (Figure 7A, 338	
7B) or severe (Table 3) exercise. Furthermore, the CV for the TD[HHb + Mb] (moderate, 339	
hyperoxia: 27 ± 14 versus normoxia: 31 ± 17%, P = 0.19; severe, hyperoxia: 62 ± 38 versus 340	
normoxia: 43 ± 21%, P = 0.65) and the τ[HHb + Mb] (moderate, hyperoxia: 41 ± 26 versus 341	
normoxia: 21 ± 15%, P = 0.11; severe, hyperoxia: 49 ± 14 versus normoxia: 57 ± 13%, P = 342	
0.21) did not differ between conditions. There were no differences in any parameters of the 343	
heart rate kinetics, apart from a reduction in the absolute amplitude of the heart rate response 344	
in hyperoxia (hyperoxia: 98 ± 2 beats.min-1 versus normoxia: 105 ± 6 beats.min-1, P = 0.005). 345	
DISCUSSION 346	
We have previously demonstrated a causal relationship between 𝑉O2 kinetics (specifically 347	
𝜏!O2) and critical power (Goulding et al., 2017, 2018a, 2018b). However, stronger evidence 348	
in favour of a determining effect of 𝜏!O2 on critical power would come from the scaling of 349	
any change in critical power (ΔCP) to that of the change in 𝜏!O2 (Δ𝜏!O2). We therefore 350	
examined the effect of hyperoxia on 𝜏!O2 and critical power compared to normoxia during 351	
supine exercise, with 𝜏!O2 being precisely determined via multiple repeated bouts of identical 352	
exercise in each condition. Our data were consistent with our first two hypotheses; hyperoxia 353	
induced a reduction in 𝜏!O2 when compared to normoxia during supine exercise, with this 354	
speeding of pulmonary 𝑉O2 kinetics being coincident with an increased critical power. 355	
However, the relationship between ΔCP and Δ𝜏!O2 was not sufficiently consistent across 356	
participants to be able to confidently assert that ΔCP scales with Δ𝜏!O2.   357	
Pulmonary 𝑉O2 kinetics are typically slower during supine compared to upright cycle 358	
exercise (Koga et al., 1999; Jones et al., 2006; Goulding et al., 2017), typically attributed to a 359	
loss of the effect of gravity, which impairs perfusion pressure due to the withdrawal of the 360	
hydrostatic gradient. Furthermore, femoral artery leg blood flow kinetics are also slower at 361	
the onset of exercise in this position (MacDonald et al., 1998), possibly due to the exercising 362	
muscles being positioned above the level of the heart, as in the present study, which has been 363	
shown to impair heart rate kinetics (Schneider et al. 2002) and thus slow the adjustment of 364	
convective O2 delivery relative to exercise performed below the level of the heart (Hughson 365	
et al. 1996).  In the present study, therefore, it was reasoned that improvements in O2 delivery 366	
afforded by hyperoxia in this body position would be expected to mitigate the extant O2 367	
delivery limitation and result in a reduction in 𝜏!O2 during both moderate and severe exercise. 368	
Consequently we observed a ~32 and 40% reduction in 𝜏!O2 in response to hyperoxia-induced 369	
increases in O2 delivery during moderate and severe exercise, respectively. The present study 370	
therefore provides the first demonstration of a hyperoxia-induced speeding of the 371	
fundamental phase of pulmonary 𝑉O2 kinetics in healthy humans performing whole-body 372	
exercise. These findings are significant for the understanding of metabolic control since they 373	
provide direct empirical support for the “tipping point” hypothesis proposed by Jones & 374	
Poole (2005).  375	
That hyperoxia alleviated an O2 delivery limitation induced by the supine body position is 376	
supported by our NIRS data. The [HHb + Mb] signal derived from NIRS represents the 377	
relative balance between O2 supply and O2 utilization within the field of interrogation (De 378	
Blasi et al., 1993; Ferrari et al., 1997; Grassi et al., 2003). In hyperoxia, baseline [HHb + 379	
Mb] was reduced prior to moderate exercise, and τ[HHb + Mb] was unchanged in the face of 380	
faster 𝑉O2 kinetics, data which are suggestive of an increased O2 availability. Furthermore, 381	
[HbO2 + MbO2] was enhanced during both moderate and severe exercise in hyperoxia despite 382	
no changes in [THb + Mb]. This observation is consistent with previous studies 383	
demonstrating that hyperoxia affords meaningful increases in arterial O2 content (CaO2) with 384	
unchanged muscle blood flow (𝑄m), such that muscle O2 delivery (the product of CaO2 and 385	
𝑄m) and thus intracellular PO2 is increased (Knight et al., 1993; Richardson et al., 1999). 386	
Collectively therefore, the present results suggest that the increased CaO2 afforded by 387	
hyperoxia raised intracellular PO2  and enabled faster 𝑉O2 kinetics at exercise onset in 388	
hyperoxia compared to normoxia.  389	
Importantly, we observed a concomitant ~14 W increase in critical power in hyperoxia 390	
compared with normoxia. This finding coheres with our previous investigations 391	
demonstrating that critical power is increased when 𝑉O2 kinetics are faster (Goulding et al., 392	
2017), and reduced when 𝑉O2 kinetics are slower (Goulding et al., 2018a, 2018b). It has 393	
previously been suggested that the inability to attain a steady-state above critical power arises 394	
because critical power represents the highest power output for which the O2 deficit can be 395	
stabilized (Rossiter, 2010; Murgatroyd et al., 2011). Since a smaller 𝜏!O2 results in a smaller 396	
O2 deficit for a given step increase in power output, this would therefore also increase the 397	
maximum power output for which the O2 deficit can be stabilised (i.e. increased critical 398	
power). 399	
The metabolic basis for this effect is likely to reside, at least in part, with the products of ATP 400	
hydrolysis within the exercising skeletal muscles. During high-intensity exercise (i.e. above 401	
the GET), there is an additional increase in ATP hydrolysis with time, such that the ATP cost 402	
of the work increases above that predicted from the linear relationship between ATP usage 403	
and power output below the GET (Grassi et al., 2015; Korzeniewski & Rossiter, 2015; 404	
Korzeniewski, 2018). Given the sigmoidal relationship between [ADP] and 𝑉O2 in vivo 405	
(Wüst et al., 2011), this additional ATP breakdown during high-intensity exercise would 406	
push [ADP] further towards the flatter portion of the curve, leading to a progressively smaller 407	
𝑉O2 response for a given elevation in [ADP]. If the exercise intensity is high enough, 408	
eventually the 𝑉O2 response to further elevations in [ADP] would become too small to meet 409	
the rising demand for ATP turnover, setting 𝑉O2 on an irrevocable trajectory towards 𝑉O2 410	
max. Critical power may therefore represent the power output at which a “critical [ADP]” is 411	
achieved during the rest-exercise transition; a low 𝜏!O2 would attenuate [ADP] accumulation 412	
during the rest-work transition, thus enabling a higher power to be achieved before a critical 413	
[ADP] is attained and accounting for a causal relationship with critical power.  414	
Given this proposed mechanism for a causal relationship between 𝜏!O2 and critical power, the 415	
examination of the ΔCP-Δ𝜏!O2 relationship between conditions was central to the present 416	
study.  Though our previous data suggests a determining effect of 𝜏!O2 on critical power 417	
(Goulding et al., 2017, 2018a, 2018b); such causality would be more strongly inferred if ΔCP 418	
scaled with Δ𝜏!O2.  Hence critical power and precise measures of 𝜏!O2 were derived in each 419	
condition, the latter via multiple bouts of identical exercise that were otherwise unobtainable 420	
in previous investigations (Goulding et al., 2017, 2018a, 2018b). Despite the observation of a 421	
concomitant reduction in 𝜏!O2 and increase in critical power in hyperoxia in the present 422	
study, the ΔCP-Δ𝜏!O2 relationship was not consistent across all participants (Fig. 5C). Such a 423	
finding thus questions the ubiquity of a causal relationship between 𝜏!O2 and critical power 424	
and may indicate that, as previously suggested (Goulding et al., 2017), the relative 425	
importance of 𝜏!O2 in determining critical power may be dependent upon the presence or 426	
absence of an O2 availability limitation to 𝜏!O2. Indeed a consistent feature of exercise in the 427	
supine position is the lack of an association between critical power and 𝜏!O2 (Goulding et al., 428	
2017, 2018b), which was restored in hyperoxia (r = -0.89, Figure 5B). Moreover, the 429	
concentration of a given respiratory regulator (e.g. ADP, Pi, NADH + H+, etc.) required to 430	
elicit a given 𝑉O2 is dependent upon the intracellular PO2 (Wilson et al., 1979; Wilson & 431	
Erecińska, 1985; Rumsey et al., 1990; Hogan et al., 1992a, 1992b). Hence the increased 432	
intracellular PO2 afforded by hyperoxia could have reduced the intracellular perturbations in 433	
[ADP] required to elicit a given 𝑉O2 and independently increased the work-rate at which a 434	
“critical [ADP]”, and thus critical power, was attained.  435	
However, this interpretation of the data in Figure 5 is not consistent with our previous study 436	
in the supine position demonstrating that a slowing of 𝑉O2 kinetics via work-to-work 437	
exercise, independent of the extant O2 delivery limitation, reduced critical power (Goulding 438	
et al., 2018b). The lack of association between 𝜏!O2 and critical power in the supine position 439	
can thus be alternatively explained by this body position introducing a kinetic dissociation 440	
between pulmonary and muscle 𝑉O2 (𝑉O2m; the former being a proxy of the latter) due to the 441	
inherent low baseline O2 availability and slow O2 delivery kinetics (Barstow et al., 1990; 442	
Benson et al., 2013). Computer modelling shows that this would cause pulmonary 𝑉O2 443	
kinetics to become faster than 𝑉O2m kinetics (Benson et al., 2013), dissociating 𝜏!O2 from 444	
𝜏!O2m and obscuring the critical power - 𝜏!O2 relationship. Improvements in O2 availability 445	
due to hyperoxia would thus reverse the otherwise impaired O2 availability and restore the 446	
kinetic coupling between pulmonary and muscle 𝑉O2 kinetics (see Figure 5B). Such an 447	
explanation retains consistency with our previous data both in the upright and supine 448	
positions (Goulding et al., 2018a, 2018b) and thus supports the notion of a prevailing 449	
dependency of critical power on 𝜏!O2. The inconsistent ΔCP-Δ𝜏!O2 relationship is therefore 450	
likely due to moving between conditions where the absolute values of 𝜏!O2m and 𝜏!O2 are and 451	
are not dissociated.  452	
In contrast to other reports of the effect of hyperoxia on critical power & W’ (Vanhatalo et 453	
al., 2010), whilst critical power increased, W’ remained unchanged. We also observed an 454	
increased 𝑉O2 slow component amplitude in the present study in hyperoxia, a finding that 455	
contrasts with previous reports of a decreased slow component amplitude in hyperoxia 456	
(Haseler et al., 2004; Wilkerson et al., 2006). However, in these studies the slow component 457	
was measured over a 6 minute period, whereas in the present study exercise was continued 458	
until the limit of tolerance. In contrast, in the present study, the fundamental 𝑉O2 amplitude 459	
was unchanged with an increased 𝑉O2 peak, necessitating an increased 𝑉O2 slow component. 460	
However, since there was a concomitant increase in critical power and 𝑉O2 peak, this likely 461	
determined the unchanged W’. Additionally, the 𝑉O2 slow component amplitude is greatest at 462	
work rates nearest to critical power (Poole et al., 1994); since critical power was increased in 463	
hyperoxia, this would have caused the criterion trials to be conducted in closer proximity to 464	
critical power and thus raise the 𝑉O2 slow component relative to normoxia.  465	
In summary, the present finding of a reduction in 𝜏!O2 and increase in critical power during 466	
supine exercise in hyperoxia provides further support for the notion that 𝜏!O2 is an 467	
independent determinant of critical power. However, the inconsistent relationship between 468	
ΔCP and Δ𝜏!O2 does not permit the exclusion of a role for O2 availability per se, at least in 469	
the supine position where O2 availability is limiting. Hence, despite our previous findings 470	
(Goulding et al., 2018b) the absence of a relationship between 𝜏!O2 and critical power in 471	
normoxia, and its subsequent restoration in hyperoxia may be considered as supportive for a 472	
predominant role of O2 availability in determining critical power during supine exercise. 473	
Equally however, in line with our previous study this finding may reflect a kinetic distortion 474	
between pulmonary and muscle 𝑉O2 in the supine position between 𝜏!O2 and critical power 475	
that is restored in hyperoxic conditions. Hence, despite our previous findings (Goulding et 476	
al., 2018b), further research is required to precisely elucidate the relative contributions of 477	
𝜏!O2 and O2 as determining factors for critical power.  478	
 479	
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Table 1. The critical power and W’ estimates for each participant in normoxia and hyperoxia  
 Critical power (W) W’ (kJ) 
Participant Normoxia Hyperoxia Δ (%) Normoxia Hyperoxia Δ (%) 
1 98 115 17.0 8.9 6.2 -30.9 
2 130 133 2.1 13.3 13.9 4.1 
3 181 196 8.8 19.0 21.3 12.3 
4 154 159 3.0 7.9 7.9 -1.3 
5 139 151 8.7 14.6 14.0 -4.5 
6 111 124 12.0 10.9 14.6 33.9 
7 146 183 25.2 21.7 10.6 -51.3 
8 114 127 10.8 15.1 14.1 -6.3 
Mean  134    149 * 10.9 13.9 12.8 -5.5 
S.D 27 29 7.5 4.7 4.7 26.0 
Δ is the percentage difference between conditions. * indicates significantly difference from normoxia (P < 0.05). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Table 2. Pulmonary oxygen uptake responses to severe-intensity 
constant work rate exercise in each condition.  
Parameter Normoxia Hyperoxia 
𝑉O2 baseline,  L.min-1   
WR 1 1.02 ± 0.07 1.03 ± 0.13 
WR 2 1.12 ± 0.13 1.00 ± 0.12 
WR 3 0.99 ± 0.10 1.00 ± 0.22 
WR 4 1.04 ± 0.12 0.97 ± 0.12 
𝑇𝐷!!!, s  
WR 1 9 ± 7 13 ± 6 
WR 2 13 ± 12 14 ± 10 
WR 3 6 ± 9 14 ± 11 
WR 4 16 ± 9 18 ± 4 
𝜏!O2, s 
WR 1 51 ± 12 34 ± 15 
WR 2 57 ± 21 39 ± 7 
WR 3 54 ± 8 28 ± 13 
WR 4 47 ± 17 32 ± 13 
𝐴!!!,  L.min
-1  
WR 1 1.72 ± 0.36 1.71 ± 0.62 
WR 2 1.94 ± 0.42 2.16 ± 0.48 
WR 3 2.26 ± 0.52 2.15 ± 0.65  
WR 4 2.28 ± 0.53 2.39 ± 0.43  
Absolute 𝐴!!!,  L.min
-1  
WR 1 2.72 ± 0.39 2.74 ± 0.62 
WR 2 2.93 ± 0.41 3.07 ± 0.51 
WR 3 3.26 ± 0.69 3.15 ± 0.73 
WR 4 3.32 ± 0.49 3.36 ± 0.38 
𝑆𝐶!!!,  L.min
-1  
WR 1 0.45 ± 0.34 0.81 ± 0.34 
WR 2 0.27 ± 0.38 0.51 ± 0.34 
WR 3 0.05 ± 0.09 0.45 ± 0.25 
WR 4 0.00 ± 0.00 0.17 ± 0.51 
End-exercise 𝑉O2 (L.min-1)   
WR 1 3.16 ± 0.44 3.55 ± 0.63 
‡	
*
*	
*‡	
‡	
 648	
 649	
 650	
 651	
 652	
 653	
 654	
 655	
 656	
 657	
 658	
 659	
 660	
 661	
 662	
 663	
 664	
 665	
 666	
 667	
WR 2 3.31 ± 0.63 3.66 ± 0.73 
WR 3 3.14 ± 0.58 3.62 ± 0.68 
WR 4 3.11 ± 0.51 3.54 ± 0.73 
𝑇𝐷!!! , fundamental time delay;  𝜏!O2, fundamental time constant; 𝜏!O2 
95% CI, 95% confidence interval associated with the fundamental time 
constant;  𝐴!!!, fundamental amplitude;  Absolute 𝐴!!!, baseline 𝑉O2 
+ fundamental 𝑉O2 amplitude; Gain, increase in fundamental phase 
𝑉O2 per unit increase in power output; 𝑆𝐶!!!, magnitude of the 𝑉O2 
slow component. * indicates significant main effect of condition, ‡ 
indicates significant main effect of work rate (P < 0.05).   
Table 3. Muscle deoxygenation kinetic responses at each power output for both muscle sites in 
normoxia and hyperoxia. 
 Rectus Femoris Vastus Lateralis 
Parameter Normoxia Hyperoxia Normoxia Hyperoxia 
[HHb+Mb](b), µM     
WR 1 19.3 ± 8.3 19.1 ± 10.6 20.8 ± 6.4 20.1 ± 7.3 
WR 2 21.7 ± 9.5 19.2 ± 8.6 18.9 ± 7.7 22.5 ± 8.2 
WR 3 19.7 ± 11.3 18.8 ± 8.7 23.2 ± 7.5 17.6 ± 9.6 
WR 4 16.7 ± 8.3 18.7 ± 8.1 20.5 ± 9.4 18.9 ± 4.3 
TD[HHb+Mb], s  
WR 1 10 ± 5 7 ± 3 7 ± 7 4 ± 3 
WR 2 4 ± 2 7 ± 7 6 ± 6 5 ± 3 
WR 3 5 ± 8 5 ± 3 3 ± 2 5 ± 8 
WR 4 4 ± 3 10 ± 5 5 ± 3 11 ± 6 
τ[HHb+Mb], s 
WR 1 19 ± 10 16 ± 11 10 ± 3 13 ± 11 
WR 2 24 ± 15 21 ± 21 9 ± 4 9 ± 3 
WR 3 21 ± 7 19 ± 14 10 ± 4 13 ± 8 
WR 4 21 ± 10 19 ± 10 9 ± 3 6 ± 3 
A[HHb+Mb],  µM 
WR 1 8.2 ± 3.7 5.4 ± 3.6 19.0 ± 18.4 19.0 ± 19.1 
WR 2 9.3 ± 5.5 7.2 ± 5.6 20.5 ± 16.2 19.8 ± 16.6 
WR 3 8.4 ± 5.5 9.7 ± 7.1 24.1 ± 19.7 20.2 ± 16.6 
WR 4 10.9 ± 6.5 11.3 ± 5.2 18.7 ± 16.5 18.0 ± 17.5 
Absolute  A[HHb+Mb],  µM     
WR 1 27.5 ± 11.7 24.6 ± 11.0 39.7 ± 21.6 39.1 ± 23.5 
WR 2 29.9 ± 11.9 26.4 ± 11.5 36.9 ± 22.2 42.4  ± 21.7 
WR 3 27.0 ± 13.7 28.6 ± 12.2  41.4 ± 26.2 37.8 ± 25.1 
WR 4 27.5 ± 14.2 30.0 ± 12.0  39.1 ± 24.3 36.9 ± 20.3 
SC[HHb+Mb],  µM 
WR 1 2.6 ± 3.7 6.2 ± 17.0 2.3 ± 2.9 0.0 ± 9.8 
WR 2 3.9 ± 7.3 8.1 ± 15.2 2.0 ± 2.9 0.0 ± 3.9 
WR 3 1.1 ± 1.7 0.0 ± 2.6 0.0 ± 4.9 1.6 ± 3.7 
WR 4 0.1 ± 2.2 0.0 ± 1.2 0.0 ± 15.7 0.1 ± 1.5 
End-exercise [HHb + 
Mb] (µM) 
    
WR 1 30.1 ± 12.6 30.8 ± 22.0 42.0 ± 22.5 36.1 ± 17.4 
WR 2 33.7 ± 14.1 34.5 ± 18.4 39.4 ± 23.5 42.3 ± 21.2 
# 	
 668	
 669	
 670	
 671	
 672	
 673	
 674	
 675	
 676	
 677	
 678	
 679	
 680	
 681	
 682	
 683	
 684	
WR 3 28.1 ± 14.4 28.5 ± 13.1 40.1 ± 23.8 39.4 ± 24.2 
WR 4 27.6 ± 13.0 30.0 ± 11.7 34.2 ± 17.2 37.1 ± 19.6 
[HHb+Mb](b), mean [HHb+Mb] over last 30 s of baseline; TD[HHb+Mb], time delay before 
exponential rise in [HHb+Mb]; τ[HHb+Mb], time constant of [HHb+Mb] response; A[HHb+Mb], 
amplitude of [HHb+Mb] response;  Absolute  A[HHb+Mb],  baseline [HHb + Mb] + amplitude [HHb + 
Mb]; SC[HHb+Mb], magnitude of the [HHb+Mb] slow component; End-exercise [HHb + Mb], mean 
[HHb + Mb] during finals 30 s of exercise. # indicates significant main effect of muscle (P < 0.05).  
 
FIGURE LEGENDS 685	
Figure 1. Group relationship between subcutaneous adipose tissue thickness (ATT) and 686	
resting total haemoglobin ([THb + Mb]) measured by NIRS in the rectus femoris (A; RF) and 687	
vastus lateralis (B; VL). Normalization procedure is detailed in the methods section. 688	
Figure 2. The hyperbolic power-duration relationship (A; equation 4) and the linear work-689	
time relationship (B; equation 5) in normoxia (clear circles) and hyperoxia (black circles) in 690	
participant 5. In A, the critical power is the power asymptote and W’ is the curvature constant. 691	
In B, the critical power is the gradient and the W’ is the y-intercept of the linear regression. 692	
Figure 3. Group mean pulmonary oxygen uptake (𝑉O2) responses to moderate exercise in 693	
normoxia (dashed grey line) and hyperoxia (solid black line). Group mean exponential fits 694	
are overlaid onto the 𝑉O2 responses as solid curved lines to highlight differences between 695	
conditions. Error bars omitted for clarity. FiO2; fraction of inspired O2. 696	
Figure 4. Pulmonary oxygen uptake (𝑉O2) responses and best-fit modelled responses of a 697	
representative participant at a single work rate during severe exercise in the normoxic (grey 698	
line) and hyperoxic (black line) conditions. The time constant values for the fundamental 699	
phase of pulmonary oxygen uptake kinetics (𝜏!O2) are displayed for each transition, with the 700	
solid curved lines representing the modelled fits. Lines of residuals for each condition are 701	
displayed at the bottom. 702	
Figure 5. Correlations between critical power normalized to body mass and the time constant 703	
for the fundamental phase of pulmonary oxygen uptake kinetics (𝜏!O2) for the normoxic (A) 704	
and hyperoxic (B) conditions during moderate exercise. The relationship between the change 705	
in critical power (ΔCP) and the change in 𝜏!O2 (Δ𝜏!O2) is also displayed. The correlation 706	
shown in B was significant (P < 0.001). 707	
Figure 6. Comparisons of group means ± SD during moderate exercise across both muscles 708	
for oxyhaemoglobin (A & B; [HbO2 + MbO2]) and total haemoglobin (C & D; [THb + Mb]) 709	
between conditions. Responses for the rectus femoris (RF) are displayed in A and C, whereas 710	
vastus lateralis (VL) is displayed in B and D. Open circles, normoxia; closed circles, 711	
hyperoxia. * indicates significant difference between conditions (P > 0.05). 712	
Figure 7. Group mean muscle deoxyhaemoglobin (HHb + Mb) responses to moderate 713	
exercise in the rectus femoris (A; RF) and the vastus lateralis (B; VL). Error bars omitted for 714	
clarity. Dashed vertical line indicates exercise onset. FiO2; fraction of inspired O2. 715	
 716	
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